AMENDED AND RESTATED STOCK PLEDGE AGREEMENTStock Pledge Agreement • December 19th, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Texas
Contract Type FiledDecember 19th, 2022 Company Industry JurisdictionThis AMENDED AND RESTATED STOCK PLEDGE AGREEMENT, dated as of December 7, 2022 (as amended, supplemented or otherwise modified from time to time in accordance with the provisions hereof, this “Agreement”), made by and between BioLife4D – SM Trust, dated November 1, 2016, a trust organized under the laws of the State of Illinois (the “Pledgor”), in favor of GARY E. REYNOLDS, an individual residing in the state of Texas (the “Secured Party”).
BUSINESS LOAN AGREEMENTBusiness Loan Agreement • December 19th, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances)
Contract Type FiledDecember 19th, 2022 Company IndustryTHIS BUSINESS LOAN AGREEMENT dated December 6, 2022, is made and executed between Biolife4d Corporation (“Borrower”) and Fifth Third Bank, National Association (“Lender”) on the following terms and conditions. Borrower has received prior commercial loans from Lender or has applied to Lender for a commercial loan or loans or other financial accommodations, including those which may be described on any exhibit or schedule attached to this Agreement. Borrower understands and agrees that: (A) in granting, renewing, or extending any Loan, Lender is relying upon Borrower’s representations, warranties, and agreements as set forth in this Agreement; (B) the granting, renewing, or extending of any Loan by Lender at all times shall be subject to Lender’s sole judgment and discretion; and (C) all such Loans shall be and remain subject to the terms and conditions of this Agreement.
AGREEMENTLoan Agreement • December 19th, 2022 • BioLife4D Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 19th, 2022 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is entered into as of December 6, 2022, by and among BioLife4D Corporation, a Delaware corporation (the “Company”), and BioLife4D - SM Trust (the “Trust”).